Should nephrologists consider vascular calcification screening?

Screening of vascular calcification in hemodialysis patients.

Vascular calcification (VC) is very common in subjects with chronic kidney disease (CKD), especially in hemodialysis (HD) patients, and it is becoming more prevalent with the worsening of kidney function and CKD duration. VC is associated with many adverse clinical outcomes, including ischemic cardiac events and subsequent vascular mortality (1). VC is usually seen in aging, after vascular inju...

Should psychotherapy consider reincarnation?

There is increasing recognition of the need to take into account the cultural environment and belief systems of psychotherapy patients because these values reflect basic assumptions about man's nature and the cognitive references used to cope with psychological difficulties. Currently accepted psychotherapeutic approaches take no account of the belief in life after death held by most of the wor...

Should We Consider another Booster Dose of Measles Vaccine?

Background: To date, 36 years has passed since the beginning of measles vaccination; the disease is still circulating around the world, threatening lives of human beings especially in developing countries.  In recent years, we have confronted measles in previously vaccinated adults from all over the country. Objective: To find out if there is a need for changing our routine measles vaccination ...

Erythema nodosum :what should we consider about it?

Should nephrologists use beta-blockers? A perspective.

Given the high prevalence of cardiovascular disease in people with chronic kidney disease (CKD) and the clear benefits of mortality reduction observed for most β−blockers in clinical trials, they are relatively underused in CKD patients [1,2]. The rationale for use of β-blockers in patients with CKD is reviewed in detail elsewhere [2,3] but is summarized in this editorial. Alterations in βand α...